HEALTH● LOWAug 17 · Aug 17, 2026, 2:34 PM
Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
Yahoo Finance
Eli Lilly and Company's (LLY) weight-loss pill has been approved in Europe, though Novo Nordisk A/S (NVO) retains a market advantage. This marks a new development in the competitive weight-loss drug market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH57m agoBooze at young age linked to lasting brain changesEuroNews [en]HEALTH1h agoMan who refused to leave Great Western Hospital taken to courtswindonadvertiser.co.uk · United KingdomHEALTH1h agoFree Mental Health Care For All South Australiansmiragenews.com · United StatesHEALTH1h agoTelix Completes Enrollment in Phase 3 BiPASS Study , Aligns with FDA on NDA Pathwaysingaporestar.com · Singapore